BR0014687A - Compostos de taxano pentacìclico - Google Patents

Compostos de taxano pentacìclico

Info

Publication number
BR0014687A
BR0014687A BR0014687-0A BR0014687A BR0014687A BR 0014687 A BR0014687 A BR 0014687A BR 0014687 A BR0014687 A BR 0014687A BR 0014687 A BR0014687 A BR 0014687A
Authority
BR
Brazil
Prior art keywords
taxane compounds
pentacyclic taxane
pentacyclic
compounds
unpublished
Prior art date
Application number
BR0014687-0A
Other languages
English (en)
Inventor
Tsunehiko Soga
Kouichi Uoto
Yasutuki Takeda
Original Assignee
Daiichi Seiyaku Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Seiyaku Co filed Critical Daiichi Seiyaku Co
Publication of BR0014687A publication Critical patent/BR0014687A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4355—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having oxygen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epoxy Compounds (AREA)

Abstract

"COMPOSTOS DE TAXANO PENTACìCLICO". Derivados inéditos de Taxol tendo diversos substituintes conforme representados pela fórmula geral (I) e podendo ser utilizados como compostos antitumorais que podem ser administrados por via oral.
BR0014687-0A 1999-10-15 2000-10-12 Compostos de taxano pentacìclico BR0014687A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP29335699 1999-10-15
PCT/JP2000/007087 WO2001027115A1 (fr) 1999-10-15 2000-10-12 Composes pentacycliques au taxane

Publications (1)

Publication Number Publication Date
BR0014687A true BR0014687A (pt) 2002-11-19

Family

ID=17793741

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0014687-0A BR0014687A (pt) 1999-10-15 2000-10-12 Compostos de taxano pentacìclico

Country Status (22)

Country Link
EP (1) EP1221445B1 (pt)
JP (1) JP3776799B2 (pt)
KR (1) KR100706566B1 (pt)
CN (1) CN1203074C (pt)
AR (1) AR026026A1 (pt)
AT (1) ATE405569T1 (pt)
AU (1) AU774787B2 (pt)
BR (1) BR0014687A (pt)
CA (1) CA2386772C (pt)
DE (1) DE60039998D1 (pt)
DK (1) DK1221445T3 (pt)
ES (1) ES2311473T3 (pt)
HK (1) HK1044000B (pt)
IL (2) IL149007A0 (pt)
MX (1) MXPA02003797A (pt)
MY (1) MY125378A (pt)
NO (1) NO328418B1 (pt)
PT (1) PT1221445E (pt)
RU (1) RU2257387C2 (pt)
TW (1) TWI225062B (pt)
WO (1) WO2001027115A1 (pt)
ZA (1) ZA200202696B (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2468953C (en) * 2001-11-29 2010-05-11 Daiichi Pharmaceutical Co., Ltd. Taxane derivative crystal and method for preparing the same
TW200533339A (en) 2004-03-16 2005-10-16 Bristol Myers Squibb Co Therapeutic synergy of anti-cancer compounds
ES2371947T3 (es) * 2004-04-30 2012-01-11 Daiichi Sankyo Company, Limited Proceso para producir taxano pentacíclico.
JPWO2007049575A1 (ja) * 2005-10-25 2009-04-30 第一三共株式会社 アゼチジン環構造を有するタキサン化合物
CN100516067C (zh) * 2006-01-10 2009-07-22 上海恒瑞医药有限公司 具有抗肿瘤活性的紫杉酚衍生物
US8785669B2 (en) * 2010-06-30 2014-07-22 Gfv, Llc Taxane compounds, compositions and methods
BR112014002361A2 (pt) 2011-08-02 2019-05-14 Astellas Pharma Inc. método para tratamento de câncer pelo uso combinado de fármacos
FR2986526A1 (fr) 2012-02-03 2013-08-09 Sanofi Sa Procede de preparation de derives du taxol et certains composes intermediaires
CN104650109B (zh) * 2013-11-22 2019-01-01 江苏天士力帝益药业有限公司 紫杉烷类化合物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2712289B1 (fr) * 1993-11-08 1996-01-05 Rhone Poulenc Rorer Sa Nouveaux dérivés de taxicine, leur préparation et les compositions pharmaceutiques qui les contiennent.
CN1094940C (zh) * 1995-04-28 2002-11-27 第一制药株式会社 具有抗肿瘤活性的紫杉酚衍生物
TW527183B (en) * 1996-06-06 2003-04-11 Daiichi Seiyaku Co Drug complex

Also Published As

Publication number Publication date
AR026026A1 (es) 2002-12-26
EP1221445A4 (en) 2003-05-28
DE60039998D1 (de) 2008-10-02
PT1221445E (pt) 2008-10-08
CN1409714A (zh) 2003-04-09
WO2001027115A1 (fr) 2001-04-19
CA2386772A1 (en) 2001-04-19
DK1221445T3 (da) 2008-11-24
EP1221445A1 (en) 2002-07-10
MXPA02003797A (es) 2002-12-13
ATE405569T1 (de) 2008-09-15
NO328418B1 (no) 2010-02-15
JP3776799B2 (ja) 2006-05-17
HK1044000B (zh) 2008-11-21
NO20021753D0 (no) 2002-04-12
EP1221445B1 (en) 2008-08-20
ES2311473T3 (es) 2009-02-16
TWI225062B (en) 2004-12-11
AU774787B2 (en) 2004-07-08
AU7685100A (en) 2001-04-23
CN1203074C (zh) 2005-05-25
IL149007A (en) 2006-12-10
HK1044000A1 (en) 2002-10-04
CA2386772C (en) 2009-01-13
RU2257387C2 (ru) 2005-07-27
IL149007A0 (en) 2002-11-10
KR20020035901A (ko) 2002-05-15
ZA200202696B (en) 2003-09-23
MY125378A (en) 2006-07-31
KR100706566B1 (ko) 2007-04-13
NO20021753L (no) 2002-06-12

Similar Documents

Publication Publication Date Title
LU91854I2 (fr) Eribulin et ses dérivés pharmaceutiquement acceptables (HALAVEN®)
ATE261974T1 (de) Hoch-lipophile campothecin-derivate
CY1116145T1 (el) S-φθορομεθυλεστερας 6.αλφα.,9.αλφα-διφθορο-17.αλφα.-'(2-φουρανυλκαρβοξυλ) οξυ]-11.βητα.-υδροξυ-16.αλφα.-μεθυλ-3-οξο-ανδροστ-1,4-διεν-17-καρβοθειοτικου οξεος ως αντιφλεγμονωδης παραγοντας
TR200200579T2 (tr) Amino-tirazolpiridin türevleri.
BR0215184A (pt) composições farmacêuticas de derivados de taxano oralmente ativos tendo biodisponibilidade aumentada
CY1108522T1 (el) Μεθοδος συνθεσης της περινδοπριλης και των φαρμακευτικως αποδεκτων αλατων της
MA27040A1 (fr) Nucleosides substitues en 4'
ATE99302T1 (de) Substituierte flavonoide verbindungen, ihre salze, ihre herstellung und die enthaltende arnzeizusammensetzungen.
HUP0500478A2 (hu) Taxánszármazékokat tartalmazó tumorellenes készítmények
MY129310A (en) C-4 carbonate taxanes
HUP0103203A2 (hu) Azaadamantánszármazékok és ezeket tartalmazó gyógyszerkészítmények
ATE311389T1 (de) Wirkstoffvorläufer von imidazopyridin-derivaten
BR0014687A (pt) Compostos de taxano pentacìclico
ATE360428T1 (de) Analgetisches arzneimittel
BR0104358A (pt) Formulações de taxana tendo solubilidade aperfeiçoada
NO307447B1 (no) Anvendelse av et pregnanderivat
ATE259813T1 (de) Triazolopyrimidinderivate
BR0114389A (pt) Terapia antitumor que inclui derivado de distamicina
EE200200681A (et) Akrüloüüldistamütsiini derivaati sisaldav farmatseutiline kompositsioon, derivaadi kasutamine tuumorivastase ravimi valmistamiseks ning kombineeritudravimpreparaat
PE20030236A1 (es) Derivados de bencimidazol 1-aril-2-n,s- u o-sustituidos, obtencion de medicamentos y preparados farmaceuticos que contienen estos derivados
EE200200688A (et) Akrüloüüldistamütsiini derivaati, mikrotuubulivastast toimeainet ja/või antimetaboliiti sisaldav farmatseutiline kompositsioon, derivaadi kasutamine tuumorivastase ravimi valmistamiseks ning kombineeritud ravimpreparaat
DK0760375T3 (da) Antitumor-indolopyrrolocarbazolderivater
ATE224401T1 (de) Thiocolchicosid-derivate, ihre herstellung und verwendung als arzneimittel
ECSP982682A (es) Nueva 3, 4 diariltiazolina 2- uno o 2- tiono derivados, sus metodos de preparacion y su uso terapeutico
DE60203740D1 (de) Luminacine analoge und deren verwendung

Legal Events

Date Code Title Description
B25C Requirement related to requested transfer of rights

Owner name: DAIICHI PHARMACEUTICAL CO., LTD. (JP)

Free format text: A FIM DE ATENDER O SOLICITADO NA PETICAO DE TRANSFERENCIA NO 020080043921/RJ DE 25/03/2008, REAPRESENTE O DOCUMENTO DE CESSAO COM A DEVIDA LEGALIZACAO CONSULAR.

B25A Requested transfer of rights approved

Owner name: DAIICHI SANKYO COMPANY, LIMITED (JP)

Free format text: TRANSFERIDO POR INCORPORACAO DE: DAIICHI PHARMACEUTICAL CO., LTD.

B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]

Free format text: DE ACORDO COM O ART.34 "II" DA LPI (LEI 9279, DE 14/05/96), O EXAME FICA SUSPENSO PARA QUE O REQUERENTE APRESENTE DOCUMENTOS NECESSARIOS A REGULARIZACAO DO PROCESSO E EXAME DO PEDIDO.

B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07F Notification of approval that there is no relation to art. 229 of lpi (pipeline patents) [chapter 7.6 patent gazette]

Free format text: NOTIFICACAO DE NAO ANUENCIA RELACIONADA COM O ART. 229 DA LPI

B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 14A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2275 DE 12/08/2014.